| 000395 (2013) |
Joseph B. Koroma [Sierra Leone, Burkina Faso, Royaume-Uni] ; Santigie Sesay [Sierra Leone] ; Mustapha Sonnie [Sierra Leone] ; Mary H. Hodges [Sierra Leone] ; Foday Sahr [Sierra Leone] ; Yaobi Zhang [Sénégal] ; Moses J. Bockarie [Royaume-Uni] | Impact of Three Rounds of Mass Drug Administration on Lymphatic Filariasis in Areas Previously Treated for Onchocerciasis in Sierra Leone |
| 000396 (2013) |
Taniawati Supali [Indonésie] ; Yenny Djuardi [Indonésie] ; Mark Bradley [Royaume-Uni] ; Rahmah Noordin [Malaisie] ; Paul Rückert [Indonésie] ; Peter U. Fischer [États-Unis] | Impact of Six Rounds of Mass Drug Administration on Brugian Filariasis and Soil-Transmitted Helminth Infections in Eastern Indonesia |
| 000B40 (2005) |
Tim Oqueka [Allemagne] ; Taniawati Supali [Indonésie] ; Is Suhariah Ismid [Indonésie] ; Paul Rückert [Indonésie] ; Mark Bradley [Royaume-Uni] ; Peter Fischer [Allemagne, États-Unis] | Impact of two rounds of mass drug administration using diethylcarbamazine combined with albendazole on the prevalence of Brugia timori and of intestinal helminths on Alor Island, Indonesia |
| 000494 (2012) |
Khalfan A. Mohammed ; Rinki M. Deb [Royaume-Uni] ; Michelle C. Stanton [Royaume-Uni] ; David H. Molyneux [Royaume-Uni] | Soil transmitted helminths and scabies in Zanzibar, Tanzania following mass drug administration for lymphatic filariasis - a rapid assessment methodology to assess impact |
| 000600 (2011) |
Ruth A. Ashton [Ouganda, Royaume-Uni] ; Daniel J. Kyabayinze [Ouganda] ; Tom Opio [Ouganda] ; Anna Auma [Ouganda] ; Tansy Edwards [Royaume-Uni] ; Gabriel Matwale [Ouganda] ; Ambrose Onapa [Ouganda] ; Simon Brooker [Royaume-Uni, Kenya] ; Jan H. Kolaczinski [Ouganda, Royaume-Uni] | The impact of mass drug administration and long-lasting insecticidal net distribution on Wuchereria bancrofti infection in humans and mosquitoes: an observational study in northern Uganda |
| 000602 (2011) |
Sammy M. Njenga [Kenya] ; Charles S. Mwandawiro [Kenya] ; C Njeri Wamae [Kenya] ; Dunstan A. Mukoko [Kenya] ; Anisa A. Omar [Kenya] ; Masaaki Shimada [Kenya, Japon] ; Moses J. Bockarie [Royaume-Uni] ; David H. Molyneux [Royaume-Uni] | Sustained reduction in prevalence of lymphatic filariasis infection in spite of missed rounds of mass drug administration in an area under mosquito nets for malaria control |
| 000013 (2017) |
Fasihah Taleo [Vanuatu] ; George Taleo [Vanuatu] ; Patricia M. Graves ; Peter Wood ; Sung Hye Kim [Fidji, Royaume-Uni] ; Masayo Ozaki [Fidji] ; Hayley Joseph ; Brian Chu [États-Unis] ; Alex Pavluck [États-Unis] ; Aya Yajima [Philippines] ; Wayne Melrose ; Kazuyo Ichimori [Suisse, Japon] ; Corinne Capuano [Fidji] | Surveillance efforts after mass drug administration to validate elimination of lymphatic filariasis as a public health problem in Vanuatu |
| 000127 (2016) |
Alison Krentel [Royaume-Uni] ; Rita Damayanti [Indonésie] ; Christiana Rialine Titaley [Indonésie] ; Nugroho Suharno [Indonésie] ; Mark Bradley [Royaume-Uni] ; Timothy Lynam [Australie] | Improving Coverage and Compliance in Mass Drug Administration for the Elimination of LF in Two 'Endgame' Districts in Indonesia Using Micronarrative Surveys. |
| 000241 (2015) |
Israt Hafiz [Royaume-Uni] ; Patricia Graves [Australie] ; Rouseli Haq [Bangladesh] ; Meerjady Sabrina Flora [Bangladesh] ; Louise A. Kelly-Hope [Royaume-Uni] | Clinical case estimates of lymphatic filariasis in an endemic district of Bangladesh after a decade of mass drug administration. |
| 000242 (2015) |
Maria P. Rebollo [Royaume-Uni] ; Khalfan A. Mohammed ; Brent Thomas [Royaume-Uni] ; Shaali Ame [Tanzanie] ; Said Mohammed Ali ; Jorge Cano [Royaume-Uni] ; Alba Gonzalez Escalada [Espagne] ; Moses J. Bockarie [Royaume-Uni] | Cessation of Mass Drug Administration for Lymphatic Filariasis in Zanzibar in 2006: Was Transmission Interrupted? |
| 000304 (2014) |
David H. Molyneux ; Adrian Hopkins [États-Unis] ; Mark H. Bradley [Royaume-Uni] ; Louise A. Kelly-Hope | Multidimensional complexities of filariasis control in an era of large-scale mass drug administration programmes: a can of worms |
| 000381 (2013) |
Daniel Engelman [Australie] ; Diana L. Martin [États-Unis] ; Roderick J. Hay [Royaume-Uni] ; Olivier Chosidow [France] ; James S. Mccarthy [Australie] ; L Claire Fuller [Royaume-Uni] ; Andrew C. Steer [Australie] | Opportunities to investigate the effects of ivermectin mass drug administration on scabies |
| 000423 (2013) |
Alison Krentel [États-Unis, Royaume-Uni] ; Peter U. Fischer [États-Unis] ; Gary J. Weil [États-Unis] | A Review of Factors That Influence Individual Compliance with Mass Drug Administration for Elimination of Lymphatic Filariasis |
| 000486 (2012) |
Melissa Parker [Royaume-Uni] ; Tim Allen [Royaume-Uni] | WILL MASS DRUG ADMINISTRATION ELIMINATE LYMPHATIC FILARIASIS? EVIDENCE FROM
NORTHERN COASTAL TANZANIA |
| 000510 (2012) |
Joseph B. Koroma [Sierra Leone, Royaume-Uni] ; Momodu M. Bangura [Sierra Leone] ; Mary H. Hodges [Sierra Leone] ; Mohamed S. Bah [Sierra Leone] ; Yaobi Zhang [Sénégal] ; Moses J. Bockarie [Royaume-Uni] | Lymphatic filariasis mapping by Immunochromatographic Test cards and baseline microfilaria survey prior to mass drug administration in Sierra Leone |
| 000605 (2011) |
Daniel J. Tisch [États-Unis] ; Neal D. E. Alexander [Papouasie-Nouvelle-Guinée, Royaume-Uni] ; Benson Kiniboro [Papouasie-Nouvelle-Guinée] ; Henry Dagoro [Papouasie-Nouvelle-Guinée] ; Peter M. Siba [Papouasie-Nouvelle-Guinée] ; Moses J. Bockarie [Papouasie-Nouvelle-Guinée, Royaume-Uni] ; Michael P. Alpers [Papouasie-Nouvelle-Guinée, Australie] ; James W. Kazura [États-Unis] | Reduction in Acute Filariasis Morbidity during a Mass Drug Administration Trial to Eliminate Lymphatic Filariasis in Papua New Guinea |
| 000370 (2013) |
Brajendra K. Singh [États-Unis] ; Moses J. Bockarie [Royaume-Uni] ; Manoj Gambhir [Royaume-Uni] ; Peter M. Siba [Papouasie-Nouvelle-Guinée] ; Daniel J. Tisch [États-Unis] ; James Kazura [États-Unis] ; Edwin Michael [États-Unis] | Sequential Modelling of the Effects of Mass Drug Treatments on Anopheline-Mediated Lymphatic Filariasis Infection in Papua New Guinea |
| 000C63 (2003) |
David H. Molyneux [Royaume-Uni] ; Mark Bradley ; Achim Hoerauf ; Dominique Kyelem ; Mark J. Taylor | Mass drug treatment for lymphatic filariasis and onchocerciasis. |
| 000031 (2017) |
Michelle C. Stanton [Royaume-Uni] ; Masato Yamauchi [Royaume-Uni] ; Square Z. Mkwanda [Malawi] ; Paul Ndhlovu [Malawi] ; Dorothy Emmie Matipula [Malawi] ; Charles Mackenzie [Royaume-Uni, États-Unis] ; Louise A. Kelly-Hope [Royaume-Uni] | Measuring the physical and economic impact of filarial lymphoedema in Chikwawa district, Malawi: a case-control study |
| 000041 (2017) |
Tammy Allen ; Fasihah Taleo [Vanuatu] ; Patricia M. Graves ; Peter Wood ; George Taleo [Vanuatu] ; Margaret C. Baker [États-Unis] ; Mark Bradley [Royaume-Uni] ; Kazuyo Ichimori [Japon] | Impact of the Lymphatic Filariasis Control Program towards elimination of filariasis in Vanuatu, 1997–2006 |
| 000098 (2016) |
Amy Berrington De Gonzalez [États-Unis] ; Jane A. Salotti [Royaume-Uni] ; Kieran Mchugh [Royaume-Uni] ; Mark P. Little [États-Unis] ; Richard W. Harbron [Royaume-Uni] ; Choonsik Lee [États-Unis] ; Estelle Ntowe [États-Unis] ; Melissa Z. Braganza [États-Unis] ; Louise Parker [Canada] ; Preetha Rajaraman [États-Unis] ; Charles Stiller [Royaume-Uni] ; Douglas R. Stewart [États-Unis] ; Alan W. Craft [Royaume-Uni] ; Mark S. Pearce [Royaume-Uni] | Relationship between paediatric CT scans and subsequent risk of leukaemia and brain tumours: assessment of the impact of underlying conditions |
| 000133 (2016) |
Margarida Redondo [Portugal] ; Holly Keyt [États-Unis] ; Raja Dhar [Inde] ; James D. Chalmers [Royaume-Uni] | Global impact of bronchiectasis and cystic fibrosis |
| 000148 (2016) |
Bipin Adhikari [Thaïlande] ; Nicola James [Thaïlande] ; Gretchen Newby [États-Unis] ; Lorenz Von Seidlein [Thaïlande, Royaume-Uni] ; Nicholas J. White [Thaïlande, Royaume-Uni] ; Nicholas P. J. Day [Thaïlande, Royaume-Uni] ; Arjen M. Dondorp [Thaïlande, Royaume-Uni] ; Christopher Pell [Pays-Bas] ; Phaik Yeong Cheah [Thaïlande, Royaume-Uni] | Community engagement and population coverage in mass anti-malarial administrations: a systematic literature review |
| 000155 (2016) |
Christopher Fitzpatrick [Suisse] ; Fiona M. Fleming [Royaume-Uni] ; Matthew Madin-Warburton [Suisse] ; Timm Schneider [Allemagne] ; Filip Meheus [Afrique du Sud] ; Kingsley Asiedu [Suisse] ; Anthony W. Solomon [Suisse] ; Antonio Montresor [Suisse] ; Gautam Biswas [Suisse] | Benchmarking the Cost per Person of Mass Treatment for Selected Neglected Tropical Diseases: An Approach Based on Literature Review and Meta-regression with Web-Based Software Application. |
| 000176 (2015) |
Dziedzom K. De Souza [Ghana] ; Rashid Ansumana [Royaume-Uni, Sierra Leone] ; Santigie Sessay [Sierra Leone] ; Abu Conteh [Sierra Leone] ; Benjamin Koudou [Royaume-Uni] ; Maria P. Rebollo [États-Unis] ; Joseph Koroma [Royaume-Uni] ; Daniel A. Boakye [Ghana] ; Moses J. Bockarie [Royaume-Uni] | The impact of residual infections on Anopheles-transmitted Wuchereria bancrofti after multiple rounds of mass drug administration |
| 000223 (2015) |
Michelle C. Stanton [Royaume-Uni] ; Emma L. Smith [Royaume-Uni] ; Sarah Martindale [Royaume-Uni] ; Square Z. Mkwanda [Malawi] ; Louise A. Kelly-Hope [Royaume-Uni] | Exploring hydrocoele surgery accessibility and impact in a lymphatic filariasis endemic area of southern Malawi. |
| 000248 (2015) |
Zoe Stamataki [Royaume-Uni] ; L. Brunton ; P. Lorigan ; A C Green ; J. Newton-Bishop ; A. Molassiotis | Assessing the impact of diagnosis and the related supportive care needs in patients with cutaneous melanoma. |
| 000296 (2014) |
Kelly L. Johnston [Royaume-Uni] ; Louise Ford ; Mark J. Taylor | Overcoming the challenges of drug discovery for neglected tropical diseases: the A·WOL experience. |
| 000314 (2014) |
Mark S. Schmidt [États-Unis] ; Christopher L. King [États-Unis] ; Edward K. Thomsen [Royaume-Uni] ; Peter M. Siba [Papouasie-Nouvelle-Guinée] ; Nelly Sanuku [Papouasie-Nouvelle-Guinée] ; Lawrence Fleckenstein [États-Unis] | Liquid chromatography-mass spectrometry analysis of diethylcarbamazine in human plasma for clinical pharmacokinetic studies. |
| 000338 (2014) |
D. S. M. Chan [Royaume-Uni] ; A. R. Vieira [Royaume-Uni] ; D. Aune [Royaume-Uni, Norvège] ; E. V. Bandera [États-Unis] ; D. C. Greenwood [Royaume-Uni] ; A. Mctiernan [États-Unis] ; D. Navarro Rosenblatt [Royaume-Uni] ; I. Thune [Norvège] ; R. Vieira [Royaume-Uni] ; T. Norat [Royaume-Uni] | Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies |
| 000361 (2013) |
Maria P. Rebollo [Royaume-Uni] ; Moses J. Bockarie | Toward the elimination of lymphatic filariasis by 2020: treatment update and impact assessment for the endgame. |
| 000362 (2013) |
Elizabeth Mousley [Royaume-Uni] ; Kebede Deribe [Royaume-Uni, Éthiopie] ; Abreham Tamiru [Éthiopie] ; Gail Davey [Royaume-Uni] | The impact of podoconiosis on quality of life in Northern Ethiopia |
| 000439 (2013) |
M. Ameen [Royaume-Uni] | The impact of human immunodeficiency virus‐related diseases on pigmented skin types |
| 000572 (2012) |
Ikumi Okamoto ; David Wright ; Claire Foster [Royaume-Uni] | Impact of cancer on everyday life: a systematic appraisal of the research evidence |
| 000637 (2011) |
A. D. Mace [Royaume-Uni] ; A. Taghi [Royaume-Uni] ; S. Khalil [Royaume-Uni] ; A. Sandison [Royaume-Uni] | Ectopic Sequestered Thyroid Tissue: An Unusual Cause of a Mediastinal Mass |
| 000662 (2011) |
W. Franklin Smyth [Royaume-Uni] ; Jason L. Morgan [Royaume-Uni] ; Edmund O'Kane [Royaume-Uni] ; Tommy J. Millar [Royaume-Uni] ; Venkataraman N. Ramachandran [Royaume-Uni] | The characterisation of coumarins from selected structural classes by electrospray ionisation quadrupole time‐of‐flight tandem mass spectrometry |
| 000697 (2011) |
Hilary Jefferies [Royaume-Uni] ; Collette Clifford [Royaume-Uni] | A literature review of the impact of a diagnosis of cancer of the vulva and surgical treatment |
| 000822 (2009) |
Fasil Tekola [Éthiopie, Royaume-Uni, États-Unis] ; Susan Bull [Royaume-Uni] ; Bobbie Farsides [Royaume-Uni] ; Melanie J. Newport [Royaume-Uni] ; Adebowale Adeyemo [États-Unis] ; Charles N. Rotimi [États-Unis] ; Gail Davey [Éthiopie] | Impact of social stigma on the process of obtaining informed consent for genetic research on podoconiosis: a qualitative study |
| 000868 (2009) |
Rebecca J. Moon [Royaume-Uni] ; Alice Mears [Royaume-Uni] ; Lara J. Kitteringham [Royaume-Uni] ; Peter Gonda [Royaume-Uni] ; Janice A. Kohler [Royaume-Uni] ; Justin H. Davies [Royaume-Uni] | Massive ovarian oedema: An unusual abdominal mass in infancy |
| 000890 (2008) |
Khalfan A. Mohammed [Royaume-Uni] ; Hamad J. Haji ; Albis-Francesco Gabrielli [Suisse] ; Likezo Mubila [Zimbabwe] ; Gautam Biswas [Suisse] ; Lester Chitsulo [Suisse] ; Mark H. Bradley [Royaume-Uni] ; Dirk Engels [Suisse] ; Lorenzo Savioli [Suisse] ; David H. Molyneux [Royaume-Uni] | Triple Co-Administration of Ivermectin, Albendazole and Praziquantel in Zanzibar: A Safety Study |
| 000895 (2008) |
Eric A. Ottesen [États-Unis] ; Pamela J. Hooper [États-Unis] ; Mark Bradley [Royaume-Uni] ; Gautam Biswas [Suisse] | The Global Programme to Eliminate Lymphatic Filariasis: Health Impact after 8 Years |
| 000925 (2008) |
Joshua S. Boateng [Royaume-Uni] ; Kerr H. Matthews [Royaume-Uni] ; Howard N. E. Stevens [Royaume-Uni] ; Gillian M. Eccleston [Royaume-Uni] | Wound healing dressings and drug delivery systems: A review |
| 000929 (2008) |
S. Dutta Roy [Royaume-Uni] ; V. Kasipandian [Royaume-Uni] ; J. Scally [Royaume-Uni] | Suspicious breast mass in an anticoagulated patient – is core biopsy safe? |
| 000957 (2007) |
Shona Wynd [Royaume-Uni, Australie] ; Wayne D. Melrose [Australie] ; David N. Durrheim [Australie] ; Jaime Carron [Canada] ; Margaret Gyapong [Ghana] | Understanding the community impact of lymphatic filariasis: a review of the sociocultural literature |
| 000A02 (2007) |
Margaret C. Baker [Royaume-Uni] ; Deborah A. Mcfarland [États-Unis] ; Manuel Gonzales [République dominicaine] ; Mary Janet Diaz [République dominicaine] ; David H. Molyneux [Royaume-Uni] | The impact of integrating the elimination programme for lymphatic filariasis into primary health care in the Dominican Republic |
| 000B06 (2006) |
C. Williams [Royaume-Uni] ; A. S. Highet [Royaume-Uni] | Drug‐induced delayed multiorgan hypersensitivity (DIDMOHS) |
| 000B26 (2005) |
D. Kyelem [Royaume-Uni] ; J. Medlock ; S. Sanou ; M. Bonkoungou ; B. Boatin ; D H Molyneux | Short communication: impact of long-term (14 years) bi-annual ivermectin treatment on Wuchereria bancrofti microfilaraemia. |
| 000B28 (2005) |
N E Jenkins [Royaume-Uni] ; L. Radcliffe ; Mike Beadsworth ; H. Mallinson ; Fred Nye ; Nick Beeching | Scrotal mass with fever and generalized lymphadenopathy in a young man secondary to Chlamydia trachomatis infection. |
| 000C89 (2003) |
R. K. Gendy [Royaume-Uni] ; J. A. Able [Royaume-Uni] ; R. M. Rainsbury [Royaume-Uni] | Impact of skin‐sparing mastectomy with immediate reconstruction and breast‐sparing reconstruction with miniflaps on the outcomes of oncoplastic breast surgery |
| 000D23 (2002) |
K. Poole [Royaume-Uni] ; L J Fallowfield | The psychological impact of post-operative arm morbidity following axillary surgery for breast cancer: a critical review. |
| 000D51 (2002) |
M. J. Bockarie [Papouasie-Nouvelle-Guinée] ; L. Tavul ; W. Kastens ; E. Michael [Royaume-Uni] ; J. W. Kazura [États-Unis] | Impact of untreated bednets on prevalence of Wuchereria bancrofti transmitted by Anopheles farauti in Papua New Guinea |
| 000D79 (2001) |
S. Coster [Royaume-Uni] ; K. Poole ; L J Fallowfield | The validation of a quality of life scale to assess the impact of arm morbidity in breast cancer patients post-operatively. |
| 000E39 (2001) |
M J Gill [Royaume-Uni] | Management of Antimicrobials in Infectious Diseases: Impact of Antibiotic Resistance |
| 000E67 (2001) |
J. W. Oxtoby [Royaume-Uni] ; E. Widjaja [Royaume-Uni] ; K. M. Gibson [Royaume-Uni] ; K. Uzoka [Royaume-Uni] | 3D Gadolinium-enhanced MRI Venography: Evaluation of Central Chest Veins and Impact on Patient Management |
| 000E79 (2000) |
J. Horton [Royaume-Uni] ; C. Witt ; E A Ottesen ; J K Lazdins ; D G Addiss ; K. Awadzi ; M J Beach ; V Y Belizario ; S K Dunyo ; M. Espinel ; J O Gyapong ; M. Hossain ; M M Ismail ; R L Jayakody ; P J Lammie ; W. Makunde ; D. Richard-Lenoble ; B. Selve ; R K Shenoy ; P E Simonsen ; C N Wamae ; M V Weerasooriya | An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis. |
| 001102 (1998) |
Mary E. Hern ; Mary E. Harman ; Mary E. Clement [Royaume-Uni] ; Mary E. Black | Bullous fixed drug eruption due to paracetamol with an unusual immunofluorescence pattern |
